Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study

INTRODUCTION: To evaluate long-term outcomes following stand-alone implantation of two second-generation trabecular micro-bypass stents (iStent inject(®), Glaukos Corp., San Clemente, CA, USA) in eyes with predominantly primary open-angle glaucoma (POAG) and considerable preoperative disease burden....

Descripción completa

Detalles Bibliográficos
Autores principales: Hengerer, Fritz H., Auffarth, Gerd U., Riffel, Christoffer, Conrad-Hengerer, Ina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824385/
https://www.ncbi.nlm.nih.gov/pubmed/31119690
http://dx.doi.org/10.1007/s12325-019-00984-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824385/
https://www.ncbi.nlm.nih.gov/pubmed/31119690
http://dx.doi.org/10.1007/s12325-019-00984-9

Ejemplares similares